Baxter International (NYSE:BAX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $22.00 to $23.00. They now have a "neutral" rating on the stock.
Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings
Does Baxter International (BAX) Now Look Fairly Priced After Multi-Year Share Price Slide [Yahoo! Finance]
Intravenous (IV) Solutions Market Size to Reach USD 25.10 Billion by 2033, Growing at a CAGR of 8.24% - SNS Insider [Yahoo! Finance]
Baxter International (NYSE:BAX) had its price target lowered by analysts at Barclays PLC from $36.00 to $30.00. They now have an "overweight" rating on the stock.